Exchange-traded funds, or ETFs, are a convenient and cost-effective way for investors to own a diversified, professionally ...

JPC has shown strong historical returns, but currently faces risks due to its NAV discount evaporating. Click here to find ...

MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

Investors were digesting a busy week of tariff hikes and inflation updates, as fresh retail data and earnings reports rolled ...

NATCO Pharma stock has declined 34% over six days due to disappointing Q3 FY25 results, including a 37.4% revenue drop and a ...

Warren Buffett is a big investor in the oil business, and BP's performance has been attracting investor attention in results ...

While agentic AI vendors push fear of getting left behind, businesses don’t necessarily trust them, and haven’t yet started ...

Indian IT exporter Hexaware Technologies' HEXW.NS $1 billion initial public offering was fully subscribed in the final hours of the share sale on Friday, driven largely by institutional buyers as ...

More broadly, Wall Street is thinking along the same lines. Palantir's median target price of $96 per share implies 18% ...